Metabolon (Durham, NC) a commercial-stage provider of biomarker discovery and analysis, closed a $13.1M Series D financing. Participants include Keating Capital, Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures and Fletcher Spaght.